We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Marketing and Other Materials Clause Samples

Marketing and Other Materials. The Parties shall utilize only promotional, advertising, communication, literature and other Commercialization materials (collectively, “Marketing Materials”) relating to Final Product in Japan and only conduct Co-Promotional activities for Final Product that, in each case, have been included in the applicable Long-Term Commercialization Plan and Budget or Annual Commercialization Plan and Budget, or that are otherwise approved by the JJCC or SCJ. BMKK or MJ, as determined per the Annual Commercialization Plan and Budget, shall prepare all Marketing Materials and any other promotional materials used in a given year to support the use of Final Product in Japan, under the direction of, and in accordance with the marketing and promotional strategy approved by the JJCC; provided, that all such materials shall be reviewed and approved by BMKK’s and MJ’s medical, regulatory and legal teams, and reviewed and approved by the JJCC, prior to use by BMKK or MJ; and provided, further, that the content of the Marketing Materials, once approved, need not be re-submitted for approval again prior to re-use within one (1) year of its initial approval, unless the Final Product labeling in the Approval applicable to such Marketing Materials has been changed since such prior approval date. The development of all Marketing Materials relating to Final Product in Japan shall be consistent with the applicable Long-Term Commercialization Plan and Budget and Annual Commercialization Plan and Budget, with Applicable Law, and with Final Product labeling approved by the Japanese Regulatory Authorities. In Commercializing Final Product, BMKK and MJ will be identified and described as Co-Promoting Final Product, and all Marketing Materials and other Commercialization activities, including oral presentations, direct-to-consumer advertising, patient information materials and patient benefit programs, that identify either such Party, shall identify both such Parties and shall display the MJ and BMKK Corporate Names as promoters and/or marketers with equal prominence, as permitted by Applicable Law. In addition, as a prominent part of each communication with customers and other Third Parties, the Call Center and any patient information and benefit programs that the SCJ establishes for Final Product shall clearly identify Final Product as a joint product of MJ and BMKK, developed under license from ImClone. In the event of a shortfall in the quantity of Marketing Materials, the available Mar...
Marketing and Other Materials. All marketing brochures and materials and other printed and written materials relating to Sellers' or RII's ownership of or operation of the Purchased Assets or the Business that the Seller or RII is not required by Law (as defined in Section 1.3.1) to retain (of which the Seller or RII may retain duplicates so long as the confidentiality thereof is maintained by the Seller or RII, unless disclosure thereof is required by Law);
Marketing and Other Materials. Contego authorizes Intelispan to use and reprint any literature developed by Contego for or relating to the Premium Authentication Service, including product marketing literature, white papers, marketing materials and product positioning papers. Intelispan may, at its option, reprint such materials under the Intelispan name.
Marketing and Other Materials a. Hewfant will develop marketing materials in connection with the Program. First Republic will have the right to review promptly and approve all marketing materials produced by Hewfant in connection with the Program, provided that First Republic's approval is not unreasonably withheld. First Republic will develop certain other written materials (including collection letters and loan denial letters) for use in connection with the Program. Hewfant and JHTS will have the right to promptly review and approve such materials if they are meant for external use, provided that Hewfant's and JHTS's approvals are not unreasonably withheld. b. Each party hereto owns and may use in connection with the Program certain trade and service marks. No party shall use the other's marks in any manner except to the extent and in the manner expressly authorized in writing by the other.
Marketing and Other Materials 

Related to Marketing and Other Materials

  • Proxies and Other Materials The Custodian shall cause all proxies relating to Securities which are not registered in the name of the Fund to be promptly executed by the registered holder of such Securities, without indication of the manner in which such proxies are to be voted, and shall promptly deliver to the Trust such proxies, all proxy soliciting materials and all notices relating to such Securities. With respect to the foreign Securities, the Custodian will use reasonable commercial efforts to facilitate the exercise of voting and other shareholder rights, subject to the laws, regulations and practical constraints that may exist in the country where such securities are issued. The Trust acknowledges that local conditions, including lack of regulation, onerous procedural obligations, lack of notice and other factors may have the effect of severely limiting the ability of the Trust to exercise shareholder rights.

  • Documents and Other Materials I will keep and maintain adequate and current records of all Proprietary Information and Company-Related Developments developed by me during my employment, which records will be available to and remain the sole property of the Company at all times. All files, letters, notes, memoranda, reports, records, data, sketches, drawings, notebooks, layouts, charts, quotations and proposals, specification sheets, program listings, blueprints, models, prototypes, or other written, photographic or other tangible material containing Proprietary Information, whether created by me or others, which come into my custody or possession, are the exclusive property of the Company to be used by me only in the performance of my duties for the Company. Any property situated on the Company’s premises and owned by the Company, including without limitation computers, disks and other storage media, filing cabinets or other work areas, is subject to inspection by the Company at any time with or without notice. In the event of the termination of my employment for any reason, I will deliver to the Company all files, letters, notes, memoranda, reports, records, data, sketches, drawings, notebooks, layouts, charts, quotations and proposals, specification sheets, program listings, blueprints, models, prototypes, or other written, photographic or other tangible material containing Proprietary Information, and other materials of any nature pertaining to the Proprietary Information of the Company and to my work, and will not take or keep in my possession any of the foregoing or any copies.

  • FACILITIES, EQUIPMENT AND OTHER MATERIALS Except as otherwise specifically provided in this Agreement, CONTRACTOR shall, at its sole cost and expense, furnish all facilities, equipment, and other materials which may be required for performing services pursuant to this Agreement. At COUNTY’s discretion, COUNTY may make equipment or facilities available to CONTRACTOR for CONTRACTOR’s use in furtherance of this Agreement only where a COUNTY Facility or Equipment exhibit is attached to this Agreement identifying the equipment or facilities to be used by CONTRACTOR’s personnel. If COUNTY funds equipment as part of this contract, COUNTY will retain Equipment.

  • Recordkeeping and Other Information FTIS shall create, maintain and preserve all necessary records in accordance with all applicable laws, rules and regulations. Such records are the property of the Investment Company, and FTIS will promptly surrender them to the Investment Company upon request or upon termination of this Agreement. In the event of such a request or termination, FTIS shall be entitled to make and retain copies of all records surrendered, and to be reimbursed by the Investment Company for reasonable expenses actually incurred in making such copies. FTIS will take reasonable actions to maintain the confidentiality of the Investment Company's records, which may nevertheless be disclosed to the extent required by law or by this Agreement, or to the extent permitted by the Investment Company.

  • Reports and Other Information Notwithstanding that the Issuers may not be subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act or otherwise report on an annual and quarterly basis on forms provided for such annual and quarterly reporting pursuant to rules and regulations promulgated by the SEC, the Issuers shall file with the SEC (and make available (without exhibits), without cost, to (i) Holders of the Notes, upon their request, and (ii) the Trustee, within 15 days after it files such reports and information with the SEC, to the extent not publicly available on the SEC’s ▇▇▇▇▇ system or the Parent’s or an Issuer’s public website, provided, however, that the Trustee shall have no responsibility whatsoever to determine whether such filing or any other filing described below has occurred) from and after the Issue Date, (1) within the time period then in effect under the rules and regulations of the Exchange Act with respect to the filing of a Form 10-K by a non-accelerated filer, annual reports on Form 10-K, or any successor or comparable form, containing the information required to be contained therein, or required in such successor or comparable form; (2) within the time period then in effect under the rules and regulations of the Exchange Act with respect to the filing of a Form 10-Q by a non-accelerated filer, for each of the first three fiscal quarters of each fiscal year, reports on Form 10-Q containing all quarterly information that would be required to be contained in Form 10-Q, or any successor or comparable form; and (3) within the time period then in effect under the rules and regulations of the Exchange Act with respect to the filing of a Form 8-K, after the occurrence of an event required to be therein reported, such other reports on Form 8-K, or any successor or comparable form; in each case, in a manner that complies in all material respects with the requirements specified in such form; provided that the Issuers shall not be so obligated to file such reports with the SEC if the SEC does not permit such filing, in which event the Issuers shall post such reports on the Parent’s or an Issuer’s public website within 15 days after the time they would have been required to file such information with the SEC, if they were subject to Sections 13 or 15(d) of the Exchange Act. In the event that (1) the rules and regulations of the SEC (including Rule 3-10 of Regulation S-X) permit the Issuers and the Parent (or any other direct or indirect parent company of Finance LLC), to report at such parent entity’s level on a consolidated basis and (2) either (i) such parent entity of Finance LLC is not engaged in any business in any material respect other than incidental to its ownership, directly or indirectly of the Capital Stock of Finance LLC or (ii) such parent entity of Finance LLC provides separate financial information and a Management’s Discussion and Analysis of Financial Condition and Results of Operations for Finance LLC and the Restricted Subsidiaries on the one hand, and for any other material business on the other hand, then the information and reports required by this covenant may be those of such parent company on a consolidated basis, rather than those of the Issuers. In addition, to the extent not satisfied by the foregoing, for so long as any Notes are outstanding, the Issuers shall furnish to Holders and to securities analysts and prospective investors, upon their request, the information required to be delivered pursuant to Rule 144A(d)(4) under the Securities Act. Delivery of such reports, information and documents to the Trustee is for informational purposes only and the Trustee’s receipt of such shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Issuers’ compliance with any of their covenants hereunder (as to which the Trustee is entitled to rely exclusively on Officer’s Certificates).

AI Assistant